Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a ...

The expanded application makes this the first available treatment for myasthenia gravis in children. Soliris is available only through a Risk Evaluation Management Program. The FDA has approved an ...

Treatment with inebilizumab is significantly effective and safe for patients with AChR+ or MuSK+ generalized myasthenia ...